Detalhe da pesquisa
1.
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
Circulation
; 143(1): 7-17, 2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33073614
2.
The learning curve associated with the introduction of the subcutaneous implantable defibrillator.
Europace
; 18(7): 1010-5, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26324840
3.
An entirely subcutaneous implantable cardioverter-defibrillator.
N Engl J Med
; 363(1): 36-44, 2010 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20463331
4.
Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results.
Heart Rhythm
; 16(11): 1636-1644, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31082539
5.
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.
Heart Rhythm
; 14(3): 367-375, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27890798
6.
Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort.
Circ Arrhythm Electrophysiol
; 8(5): 1159-63, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26148819
7.
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.
J Am Coll Cardiol
; 65(16): 1605-1615, 2015 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25908064
8.
Recurrent Candida parapsilosis infective endocarditis aortic root replacement.
Br J Hosp Med (Lond)
; 73(8): 468-9, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22953373